smartbax Alternatives & Competitors
12 companies similar to smartbax — Smarter antibiotics for a healthier tomorrow.
Companies similar to smartbax
Sealife PHARMA® GMBH
Pioneering breakthroughs in marine biochemistry to combat drug-resistant infections and ad...
Biocidium Biopharmaceuticals
Clinical-stage biopharmaceutical company focused on novel antibiotics, antifungals, and tr...
Canada
MGB Biopharma Limited
Delivering Novel Anti-Infectives
Glasgow, United Kingdom
Phico Therapeutics Ltd.
Phico Therapeutics is a biotechnology company advancing the war on antibiotic resistance w...
United Kingdom
Track all smartbax competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Mutabilis
New Antibiotics against Multi Resistant Gram-negative bacterial infections
Romainville, France
ContraFect Corp
...focused on discovering & developing differentiated biologic therapies for life-threaten...
Yonkers, United States
Microbion Corporation
Developing a disruptive new class of therapeutic drugs for the treatment of rare, chronic,...
Bozeman, United States
Tetraphase Pharmaceuticals
Fighting against antimicrobial resistance is at the core of our technology and our people.
Watertown, United States
Zikani Therapeutics
A new era in antibiotic treatment targeting resilient gram-negative bacteria, delivering a...
Octagon Therapeutics
Advancing antibiotic innovation for multi-drug resistant infections with a world-class tea...
Curza
Small molecule therapeutics R&D company focused on developing new drugs to combat antibiot...
Synereca Pharmaceuticals
Pioneering orally active drugs to rejuvenate antibiotic efficacy against lung, urinary tra...
About smartbax
smartbax is an innovative player in the Biotechnology sector, founded in 2021 and headquartered in Germany. The company is making significant strides against multi-drug resistant bacteria through the development of novel, multi-targeted antibacterial compounds. These compounds showcase extraordinary potency, specifical...
Research and development of new antibiotics, Preclinical studies for novel antibacterial compounds, Development of dual-targeted antibiotic approaches
Healthcare providers dealing with resistant bacterial infections, Pharmaceutical companies interested in novel antibiotic compounds, Academic institutions focusing on microbial resistance
Antibiotics, Multi-targeted, Antibacterial Compounds, Multi-drug Resistant Bacteria, Biofilms, MRSA, VRE, Pharmaceuticals, Drug Development
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches smartbax and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at smartbax on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
